| abstract |
Damage to stem cells, cells, tissues or organs obtained by culturing monocytes in the presence of at least one selected from the group consisting of (i) M-CSF and (ii) gangliosides and water soluble plant extracts and dedifferentiating Therapeutic agents for diseases associated with; The present invention relates to a cell pharmaceutical agent, a method for producing stem cells, a dedifferentiation induction medium of monocytes, a dedifferentiation inducing agent, a cell pharmaceutical kit or a dedifferentiated cell production kit, and a pharmaceutical composition. |